The profile of use of rituximab in tertiary care hospitals of central India

• Autors principals: Alok Singh (Autor), Ajaya K Sahoo (Autor), Debadulal Biswal (Autor), Pranav G Sheth (Autor), Suryaprakash Dhaneria (Autor), Dhyuti Gupta (Autor)
• Format: Llibre
• Publicat: Wolters Kluwer Medknow Publications, 2022-01-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Background: Rituximab, one of the most commonly used biologics, was once approved by the United States Food and Drug Association (US FDA) for the management of different systemic autoimmune disorders, and it is now used extensively in managing off-label indications. There is a scarcity of data regar...